Merck buying Acceleron Pharma in $11.5B deal

Merck will spend about $11.5 billion to buy Acceleron Pharma and its potential treatment for high blood pressure in vessels that connect the lungs heart.

Fuel had already been rationed due to shortages caused by Kyiv's attacks against supply routes in Russian-occupied territories. from BB...
0 comments:
Post a Comment